{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:08:56Z","timestamp":1787692136042,"version":"build-2784847793"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10067-020-05275-1","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T12:02:30Z","timestamp":1594468950000},"page":"2529-2543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":206,"title":["Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-6018","authenticated-orcid":false,"given":"Armen Yuri","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"5275_CR1","unstructured":"COVID-19 situation reports. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed 3 Jun 2020"},{"key":"5275_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1126\/science.367.6475.234","volume":"367","author":"J Cohen","year":"2020","unstructured":"Cohen J, Normile D (2020) New SARS-like virus in China triggers alarm. Science 367:234\u2013235. https:\/\/doi.org\/10.1126\/science.367.6475.234","journal-title":"Science"},{"key":"5275_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet Lond Engl"},{"key":"5275_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond 395:1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet Lond"},{"key":"5275_CR5","doi-asserted-by":"publisher","first-page":"116871","DOI":"10.1016\/j.jns.2020.116871","volume":"414","author":"F Garaci","year":"2020","unstructured":"Garaci F, Di Giuliano F, Picchi E et al (2020) Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci 414:116871. https:\/\/doi.org\/10.1016\/j.jns.2020.116871","journal-title":"J Neurol Sci"},{"key":"5275_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368:473\u2013474. https:\/\/doi.org\/10.1126\/science.abb8925","journal-title":"Science"},{"key":"5275_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"5275_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathol-020712-164041","volume":"8","author":"S Paessler","year":"2013","unstructured":"Paessler S, Walker DH (2013) Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8:411\u2013440. https:\/\/doi.org\/10.1146\/annurev-pathol-020712-164041","journal-title":"Annu Rev Pathol"},{"key":"5275_CR9","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/jmv.23354","volume":"84","author":"M Goeijenbier","year":"2012","unstructured":"Goeijenbier M, van Wissen M, van de Weg C, Jong E, Gerdes VEA, Meijers JCM, Brandjes DPM, van Gorp ECM (2012) Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol 84:1680\u20131696. https:\/\/doi.org\/10.1002\/jmv.23354","journal-title":"J Med Virol"},{"key":"5275_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(06)68474-2","volume":"367","author":"L Smeeth","year":"2006","unstructured":"Smeeth L, Cook C, Thomas S et al (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet Lond 367:1075\u20131079. https:\/\/doi.org\/10.1016\/S0140-6736(06)68474-2","journal-title":"Lancet Lond"},{"key":"5275_CR11","doi-asserted-by":"publisher","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, Vander K, Bargfrieder U, Trauner M (2020) Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, Clinicopathologic Case Series. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-2566","DOI":"10.7326\/M20-2566"},{"key":"5275_CR12","doi-asserted-by":"publisher","unstructured":"Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14817","DOI":"10.1111\/jth.14817"},{"key":"5275_CR13","doi-asserted-by":"publisher","first-page":"108214","DOI":"10.1016\/j.diabres.2020.108214","volume":"164","author":"Z Wang","year":"2020","unstructured":"Wang Z, Du Z, Zhu F (2020) Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract 164:108214. https:\/\/doi.org\/10.1016\/j.diabres.2020.108214","journal-title":"Diabetes Res Clin Pract"},{"key":"5275_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13613-020-00675-7","volume":"10","author":"FM Beloncle","year":"2020","unstructured":"Beloncle FM, Pavlovsky B, Desprez C, Fage N, Olivier PY, Asfar P, Richard JC, Mercat A (2020) Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome. Ann Intensive Care 10:55. https:\/\/doi.org\/10.1186\/s13613-020-00675-7","journal-title":"Ann Intensive Care"},{"key":"5275_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D (2020) COVID-19 does not Lead to a \u201ctypical\u201d acute respiratory distress syndrome. Am J Respir Crit Care Med 201:1299\u20131300. https:\/\/doi.org\/10.1164\/rccm.202003-0817LE","journal-title":"Am J Respir Crit Care Med"},{"key":"5275_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","volume":"151","author":"KJ Dunham-Snary","year":"2017","unstructured":"Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL (2017) Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest 151:181\u2013192. https:\/\/doi.org\/10.1016\/j.chest.2016.09.001","journal-title":"Chest"},{"key":"5275_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0039-1683896","volume":"40","author":"MC Sklar","year":"2019","unstructured":"Sklar MC, Patel BK, Beitler JR, Piraino T, Goligher E (2019) Optimal ventilator strategies in acute respiratory distress syndrome. Semin Respir Crit Care Med 40:81\u201393. https:\/\/doi.org\/10.1055\/s-0039-1683896","journal-title":"Semin Respir Crit Care Med"},{"key":"5275_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijid.2020.05.024","volume":"96","author":"H Fan","year":"2020","unstructured":"Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Zhang H, Tao X, Cheng S, Yu W, Zhu L, Chen J (2020) Cardiac injuries in patients with coronavirus disease 2019: not to be ignored. Int J Infect Dis 96:294\u2013297. https:\/\/doi.org\/10.1016\/j.ijid.2020.05.024","journal-title":"Int J Infect Dis"},{"key":"5275_CR19","doi-asserted-by":"publisher","unstructured":"Vrsalovic M, Vrsalovic Presecki A (2020) Cardiac troponins predict mortality in patients with COVID-19: a meta-analysis of adjusted risk estimates. J Inf Secur. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.022","DOI":"10.1016\/j.jinf.2020.05.022"},{"key":"5275_CR20","doi-asserted-by":"publisher","unstructured":"Zhou R (2020) Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa392","DOI":"10.1093\/eurheartj\/ehaa392"},{"key":"5275_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","volume":"192","author":"P Demelo-Rodr\u00edguez","year":"2020","unstructured":"Demelo-Rodr\u00edguez P, Cervilla-Mu\u00f1oz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Mac\u00edas M, Toledo-Samaniego N, Garc\u00eda-Garc\u00eda A, Garc\u00eda-Fern\u00e1ndez-Bravo I, Ji Z, de-Miguel-Diez J, \u00c1lvarez-Sala-Walther LA, del-Toro-Cervera J, Galeano-Valle F (2020) Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res 192:23\u201326. https:\/\/doi.org\/10.1016\/j.thromres.2020.05.018","journal-title":"Thromb Res"},{"key":"5275_CR22","doi-asserted-by":"publisher","unstructured":"Stoneham SM, Milne KM, Nuttal E, Frew GH, Sturrock BR, Sivaloganathan H, Ladikou EE, Drage S, Phillips B, Chevassut TJT, Eziefula AC (2020) Thrombotic risk in COVID-19: a case series and case-control study. Clin Med Lond:clinmed.2020\u2013clinmed.0228. https:\/\/doi.org\/10.7861\/clinmed.2020-0228","DOI":"10.7861\/clinmed.2020-0228"},{"key":"5275_CR23","doi-asserted-by":"publisher","unstructured":"(2020) Analysis on 54 mortality cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci 35. https:\/\/doi.org\/10.3346\/jkms.2020.35.e132","DOI":"10.3346\/jkms.2020.35.e132"},{"key":"5275_CR24","doi-asserted-by":"publisher","unstructured":"Galv\u00e1n Casas C, Catal\u00e0 A, Carretero Hern\u00e1ndez G et al (2020) Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.19163","DOI":"10.1111\/bjd.19163"},{"key":"5275_CR25","doi-asserted-by":"publisher","unstructured":"Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, Montin D (2020) SARS-CoV-2-induced Kawasaki-like Hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics:e20201711. https:\/\/doi.org\/10.1542\/peds.2020-1711","DOI":"10.1542\/peds.2020-1711"},{"key":"5275_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5275_CR27","doi-asserted-by":"publisher","unstructured":"Salerno M, Sessa F, Piscopo A et al (2020) No autopsies on COVID-19 deaths: a missed opportunity and the lockdown of science. J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9051472","DOI":"10.3390\/jcm9051472"},{"key":"5275_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","volume":"15","author":"S Tian","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY (2020) Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 15:700\u2013704. https:\/\/doi.org\/10.1016\/j.jtho.2020.02.010","journal-title":"J Thorac Oncol"},{"key":"5275_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8:420\u2013422. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"key":"5275_CR30","doi-asserted-by":"publisher","unstructured":"Wichmann D, Sperhake J-P, L\u00fctgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schr\u00f6der AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, P\u00fcschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-2003","DOI":"10.7326\/M20-2003"},{"key":"5275_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","volume":"153","author":"LM Barton","year":"2020","unstructured":"Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S (2020) COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol 153:725\u2013733. https:\/\/doi.org\/10.1093\/ajcp\/aqaa062","journal-title":"Am J Clin Pathol"},{"key":"5275_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 220:1\u201313. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.007","journal-title":"Transl Res"},{"key":"5275_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","volume":"33","author":"S Tian","year":"2020","unstructured":"Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao SY (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33:1007\u20131014. https:\/\/doi.org\/10.1038\/s41379-020-0536-x","journal-title":"Mod Pathol"},{"key":"5275_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","volume":"98","author":"H Su","year":"2020","unstructured":"Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98:219\u2013227. https:\/\/doi.org\/10.1016\/j.kint.2020.04.003","journal-title":"Kidney Int"},{"key":"5275_CR35","doi-asserted-by":"publisher","unstructured":"Nunes Duarte-Neto A, de Almeida Monteiro RA, da Silva LFF, Malheiros DMAC, de Oliveira EP, Theodoro Filho J, Pinho JRR, Soares Gomes-Gouv\u00eaa M, Salles APM, de Oliveira IRS, Mauad T, do Nascimento Saldiva PH, Dolhnikoff M (2020) Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy. Histopathology. https:\/\/doi.org\/10.1111\/his.14160","DOI":"10.1111\/his.14160"},{"key":"5275_CR36","doi-asserted-by":"publisher","first-page":"151530","DOI":"10.1016\/j.anndiagpath.2020.151530","volume":"46","author":"JJ Mulvey","year":"2020","unstructured":"Mulvey JJ, Magro CM, Ma LX, Nuovo GJ, Baergen RN (2020) Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Ann Diagn Pathol 46:151530. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151530","journal-title":"Ann Diagn Pathol"},{"key":"5275_CR37","doi-asserted-by":"publisher","unstructured":"Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A (2020) Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology. https:\/\/doi.org\/10.1111\/his.14134","DOI":"10.1111\/his.14134"},{"key":"5275_CR38","doi-asserted-by":"publisher","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2015432","DOI":"10.1056\/NEJMoa2015432"},{"key":"5275_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.thromres.2020.04.022","volume":"191","author":"I Martinelli","year":"2020","unstructured":"Martinelli I, Ferrazzi E, Ciavarella A, Erra R, Iurlaro E, Ossola M, Lombardi A, Blasi F, Mosca F, Peyvandi F (2020) Pulmonary embolism in a young pregnant woman with COVID-19. Thromb Res 191:36\u201337. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.022","journal-title":"Thromb Res"},{"key":"5275_CR40","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1111\/bjh.16849","volume":"190","author":"I Ahmed","year":"2020","unstructured":"Ahmed I, Azhar A, Eltaweel N, Tan BK (2020) First Covid-19 maternal mortality in the UK associated with thrombotic complications. Br J Haematol 190:e37\u2013e38. https:\/\/doi.org\/10.1111\/bjh.16849","journal-title":"Br J Haematol"},{"key":"5275_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1093526620925569","volume":"23","author":"RN Baergen","year":"2020","unstructured":"Baergen RN, Heller DS (2020) Placental pathology in Covid-19 positive mothers: preliminary findings. Pediatr Dev Pathol 23:177\u2013180. https:\/\/doi.org\/10.1177\/1093526620925569","journal-title":"Pediatr Dev Pathol"},{"key":"5275_CR42","doi-asserted-by":"publisher","unstructured":"Morassi M, Bagatto D, Cobelli M, D\u2019Agostini S, Gigli GL, Bn\u00e0 C, Vogrig A (2020) Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09885-2","DOI":"10.1007\/s00415-020-09885-2"},{"key":"5275_CR43","doi-asserted-by":"publisher","unstructured":"Yaghi S, Ishida K, Torres J et al (2020) SARS2-CoV-2 and stroke in a New York healthcare system. Stroke:STROKEAHA120030335. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030335","DOI":"10.1161\/STROKEAHA.120.030335"},{"key":"5275_CR44","doi-asserted-by":"publisher","unstructured":"Tun\u00e7 A, \u00dcnl\u00fcba\u015f Y, Alemdar M, Aky\u00fcz E (2020) Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci. https:\/\/doi.org\/10.1016\/j.jocn.2020.05.018","DOI":"10.1016\/j.jocn.2020.05.018"},{"key":"5275_CR45","doi-asserted-by":"publisher","unstructured":"Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, J\u00e4ger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry:jnnp-2020-323586. https:\/\/doi.org\/10.1136\/jnnp-2020-323586","DOI":"10.1136\/jnnp-2020-323586"},{"key":"5275_CR46","doi-asserted-by":"publisher","unstructured":"Kihira S, Schefflein J, Chung M et al (2020) Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic. J Neurointerv Surg. https:\/\/doi.org\/10.1136\/neurintsurg-2020-016188","DOI":"10.1136\/neurintsurg-2020-016188"},{"key":"5275_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","volume":"87","author":"A Avula","year":"2020","unstructured":"Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, Glaser A, Elsayegh D (2020) COVID-19 presenting as stroke. Brain Behav Immun 87:115\u2013119. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.077","journal-title":"Brain Behav Immun"},{"key":"5275_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Alexia B, Sandri MT, Barco S, Humanitas COVID-19 Task Force (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9\u201314. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.024","journal-title":"Thromb Res"},{"key":"5275_CR49","doi-asserted-by":"publisher","unstructured":"Llitjos J-F, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K (2020) High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14869","DOI":"10.1111\/jth.14869"},{"key":"5275_CR50","doi-asserted-by":"publisher","unstructured":"Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M\u00fcller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N (2020) Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14888","DOI":"10.1111\/jth.14888"},{"key":"5275_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148\u2013150. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.041","journal-title":"Thromb Res"},{"key":"5275_CR52","doi-asserted-by":"publisher","first-page":"201955","DOI":"10.1148\/radiol.2020201955","volume":"201955","author":"N Poyiadji","year":"2020","unstructured":"Poyiadji N, Cormier P, Patel PY et al (2020) Acute pulmonary embolism and COVID-19. Radiology 201955:201955. https:\/\/doi.org\/10.1148\/radiol.2020201955","journal-title":"Radiology"},{"key":"5275_CR53","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089\u20131098. https:\/\/doi.org\/10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"5275_CR54","doi-asserted-by":"publisher","unstructured":"Grillet F, Behr J, Calame P et al (2020) Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology 201544. https:\/\/doi.org\/10.1148\/radiol.2020201544","DOI":"10.1148\/radiol.2020201544"},{"key":"5275_CR55","doi-asserted-by":"publisher","unstructured":"Bompard F, Monnier H, Saab I et al (2020) Pulmonary embolism in patients with Covid-19 pneumonia. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01365-2020","DOI":"10.1183\/13993003.01365-2020"},{"key":"5275_CR56","doi-asserted-by":"publisher","unstructured":"Griffin DO, Jensen A, Khan M, Chin J, Chin K, Saad J, Parnell R, Awwad C, Patel D (2020) Pulmonary embolism and increased levels of D-dimer in patients with Coronavirus disease. Emerg Infect Dis 26. https:\/\/doi.org\/10.3201\/eid2608.201477","DOI":"10.3201\/eid2608.201477"},{"key":"5275_CR57","doi-asserted-by":"publisher","first-page":"201561","DOI":"10.1148\/radiol.2020201561","volume":"201561","author":"I Leonard-Lorant","year":"2020","unstructured":"Leonard-Lorant I, Delabranche X, Severac F, Helms J, Pauzet C, Collange O, Schneider F, Labani A, Bilbault P, Moliere S, Leyendecker P, Roy C, Ohana M (2020) Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels. Radiology 201561:201561. https:\/\/doi.org\/10.1148\/radiol.2020201561","journal-title":"Radiology"},{"key":"5275_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/CCM.0000000000000713","volume":"43","author":"W Lim","year":"2015","unstructured":"Lim W, Meade M, Lauzier F et al (2015) Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med 43:401\u2013410. https:\/\/doi.org\/10.1097\/CCM.0000000000000713","journal-title":"Crit Care Med"},{"key":"5275_CR59","doi-asserted-by":"publisher","unstructured":"Tee A, Wong A, Yusuff T et al (2020) Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-06085-4","DOI":"10.1007\/s00134-020-06085-4"},{"key":"5275_CR60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00134-020-05996-6","volume":"46","author":"Q-Y Peng","year":"2020","unstructured":"Peng Q-Y, Wang X-T, Zhang L-N, Chinese Critical Care Ultrasound Study Group (CCUSG) (2020) Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med 46:849\u2013850. https:\/\/doi.org\/10.1007\/s00134-020-05996-6","journal-title":"Intensive Care Med"},{"key":"5275_CR61","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jvsv.2019.02.011","volume":"7","author":"JM Lurie","year":"2019","unstructured":"Lurie JM, Png CYM, Subramaniam S, Chen S, Chapman E, Aboubakr A, Marin M, Faries P, Ting W (2019) Virchow\u2019s triad in \u201csilent\u201d deep vein thrombosis. J Vasc Surg Venous Lymphat Disord 7:640\u2013645. https:\/\/doi.org\/10.1016\/j.jvsv.2019.02.011","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"5275_CR62","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.burns.2018.09.032","volume":"45","author":"N Alturki","year":"2019","unstructured":"Alturki N, Alkahtani M, Daghistani M, Alyafi T, Khairy S, Ashi M, Aljuffri A (2019) Incidence and risk factors for deep vein thrombosis among pediatric burn patients. Burns 45:560\u2013566. https:\/\/doi.org\/10.1016\/j.burns.2018.09.032","journal-title":"Burns"},{"key":"5275_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson T, Shantsila E, Lip GYH (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited. Lancet Lond 373:155\u2013166. https:\/\/doi.org\/10.1016\/S0140-6736(09)60040-4","journal-title":"Lancet Lond"},{"key":"5275_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","volume":"276","author":"P Raggi","year":"2018","unstructured":"Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M (2018) Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 276:98\u2013108. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.014","journal-title":"Atherosclerosis"},{"key":"5275_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41582-019-0221-1","volume":"15","author":"G Stoll","year":"2019","unstructured":"Stoll G, Nieswandt B (2019) Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nat Rev Neurol 15:473\u2013481. https:\/\/doi.org\/10.1038\/s41582-019-0221-1","journal-title":"Nat Rev Neurol"},{"key":"5275_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1874192401004020071","volume":"4","author":"M La Regina","year":"2010","unstructured":"La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Beh\u00e7et\u2019s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71\u201377. https:\/\/doi.org\/10.2174\/1874192401004020071","journal-title":"Open Cardiovasc Med J"},{"key":"5275_CR67","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803\u2013815. https:\/\/doi.org\/10.1038\/nri2171","journal-title":"Nat Rev Immunol"},{"key":"5275_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"L-A Teuwen","year":"2020","unstructured":"Teuwen L-A, Geldhof V, Pasut A, Carmeliet P (2020) COVID-19: the vasculature unleashed. Nat Rev Immunol 20:389\u2013391. https:\/\/doi.org\/10.1038\/s41577-020-0343-0","journal-title":"Nat Rev Immunol"},{"key":"5275_CR69","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-2000-13202","volume":"26","author":"PL Gross","year":"2000","unstructured":"Gross PL, Aird WC (2000) The endothelium and thrombosis. Semin Thromb Hemost 26:463\u2013478. https:\/\/doi.org\/10.1055\/s-2000-13202","journal-title":"Semin Thromb Hemost"},{"key":"5275_CR70","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/cvr\/cvv240","volume":"108","author":"JD Pearson","year":"2015","unstructured":"Pearson JD (2015) Plasticity of adult endothelium: how frequent and to what extent? Cardiovasc Res 108:319\u2013320. https:\/\/doi.org\/10.1093\/cvr\/cvv240","journal-title":"Cardiovasc Res"},{"key":"5275_CR71","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran P, Rengarajan T, Thangavel J et al (2013) The vascular endothelium and human diseases. Int J Biol Sci 9:1057\u20131069. https:\/\/doi.org\/10.7150\/ijbs.7502","journal-title":"Int J Biol Sci"},{"key":"5275_CR72","doi-asserted-by":"publisher","first-page":"208108","DOI":"10.1155\/2012\/208108","volume":"2012","author":"T Urano","year":"2012","unstructured":"Urano T, Suzuki Y (2012) Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA. J Biomed Biotechnol 2012:208108. https:\/\/doi.org\/10.1155\/2012\/208108","journal-title":"J Biomed Biotechnol"},{"key":"5275_CR73","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2353\/ajpath.2007.060469","volume":"170","author":"J Ye","year":"2007","unstructured":"Ye J, Zhang B, Xu J et al (2007) Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol 170:538\u2013545. https:\/\/doi.org\/10.2353\/ajpath.2007.060469","journal-title":"Am J Pathol"},{"key":"5275_CR74","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"key":"5275_CR75","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"5275_CR76","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"5275_CR77","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1182\/blood-2011-05-353912","volume":"118","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Yasui H, Brzoska T, Mogami H, Urano T (2011) Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells. Blood 118:3182\u20133185. https:\/\/doi.org\/10.1182\/blood-2011-05-353912","journal-title":"Blood"},{"key":"5275_CR78","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle B (2020) Severe COVID-19 infection associated with endothelial activation. Thromb Res 190:62. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.014","journal-title":"Thromb Res"},{"key":"5275_CR79","doi-asserted-by":"publisher","unstructured":"McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C (2020) The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 102537. https:\/\/doi.org\/10.1016\/j.autrev.2020.102537","DOI":"10.1016\/j.autrev.2020.102537"},{"key":"5275_CR80","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.clim.2020.108487","volume":"108487","author":"L Roncati","year":"2020","unstructured":"Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, Nasillo V, Manenti A, Maiorana A (2020) Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol Orlando Fla 108487:108487. https:\/\/doi.org\/10.1016\/j.clim.2020.108487","journal-title":"Clin Immunol Orlando Fla"},{"key":"5275_CR81","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1055\/s-0035-1556730","volume":"41","author":"N Semeraro","year":"2015","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M (2015) Coagulopathy of acute Sepsis. Semin Thromb Hemost 41:650\u2013658. https:\/\/doi.org\/10.1055\/s-0035-1556730","journal-title":"Semin Thromb Hemost"},{"key":"5275_CR82","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K et al (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2:e437\u2013e445. https:\/\/doi.org\/10.1016\/S2665-9913(20)30121-1","journal-title":"Lancet Rheumatol"},{"key":"5275_CR83","doi-asserted-by":"publisher","unstructured":"Maier CL, Truong AD, Auld SC et al (2020) COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Lancet Lond. https:\/\/doi.org\/10.1016\/S0140-6736(20)31209-5","DOI":"10.1016\/S0140-6736(20)31209-5"},{"issue":"Suppl 2","key":"5275_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00003495-198700332-00006","volume":"33","author":"S Forconi","year":"1987","unstructured":"Forconi S, Pieragalli D, Guerrini M, Galigani C, Cappelli R (1987) Primary and secondary blood hyperviscosity syndromes, and syndromes associated with blood hyperviscosity. Drugs 33(Suppl 2):19\u201326. https:\/\/doi.org\/10.2165\/00003495-198700332-00006","journal-title":"Drugs"},{"key":"5275_CR85","doi-asserted-by":"publisher","unstructured":"Bi X, Su Z, Yan H et al (2020) Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets:1\u20136. https:\/\/doi.org\/10.1080\/09537104.2020.1760230","DOI":"10.1080\/09537104.2020.1760230"},{"key":"5275_CR86","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, Liu F, Wu KL, Li J, Liu XH, Zhu CL (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 58:1116\u20131120. https:\/\/doi.org\/10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"key":"5275_CR87","doi-asserted-by":"publisher","unstructured":"Ranucci M, Ballotta A, Di Dedda U et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14854","DOI":"10.1111\/jth.14854"},{"key":"5275_CR88","doi-asserted-by":"publisher","unstructured":"Bray MA, Sartain SA, Gollamudi J, Rumbaut RE (2020) MICROVASCULAR thrombosis: experimental and clinical implications. Transl Res J Lab Clin Med. https:\/\/doi.org\/10.1016\/j.trsl.2020.05.006","DOI":"10.1016\/j.trsl.2020.05.006"},{"key":"5275_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.avsg.2020.05.011","volume":"66","author":"LF Rinaldi","year":"2020","unstructured":"Rinaldi LF, Marazzi G, Marone EM (2020) Endovascular treatment of a ruptured pararenal abdominal aortic aneurysm in a COVID-19 patient: suggestions and case report. Ann Vasc Surg 66:18\u201323. https:\/\/doi.org\/10.1016\/j.avsg.2020.05.011","journal-title":"Ann Vasc Surg"},{"key":"5275_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.avsg.2020.05.001","volume":"66","author":"M Shih","year":"2020","unstructured":"Shih M, Swearingen B, Rhee R (2020) Ruptured abdominal aortic aneurysm treated with endovascular repair in a patient with active COVID-19 infection during the pandemic. Ann Vasc Surg 66:14\u201317. https:\/\/doi.org\/10.1016\/j.avsg.2020.05.001","journal-title":"Ann Vasc Surg"},{"key":"5275_CR91","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.avsg.2020.05.012","volume":"66","author":"K Powezka","year":"2020","unstructured":"Powezka K, Khan T, Narlawar R, Antoniou GA (2020) Ruptured popliteal artery aneurysm complicated with acute respiratory distress syndrome secondary to SARS-CoV-2 infection. Ann Vasc Surg 66:24\u201327. https:\/\/doi.org\/10.1016\/j.avsg.2020.05.012","journal-title":"Ann Vasc Surg"},{"key":"5275_CR92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271\u2013280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell."},{"key":"5275_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F (2020) The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 76:14\u201320. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.037","journal-title":"Eur J Intern Med"},{"key":"5275_CR94","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1160\/TH12-06-0396","volume":"108","author":"RA Fraga-Silva","year":"2012","unstructured":"Fraga-Silva RA, Da Silva DG, Montecucco F et al (2012) The angiotensin-converting enzyme 2\/angiotensin-(1-7)\/mas receptor axis: a potential target for treating thrombotic diseases. Thromb Haemost 108:1089\u20131096. https:\/\/doi.org\/10.1160\/TH12-06-0396","journal-title":"Thromb Haemost"},{"key":"5275_CR95","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1182\/blood-2012-09-459156","volume":"121","author":"C Fang","year":"2013","unstructured":"Fang C, Stavrou E, Schmaier AA et al (2013) Angiotensin 1-7 and mas decrease thrombosis in Bdkrb2\u2212\/\u2212 mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. Blood 121:3023\u20133032. https:\/\/doi.org\/10.1182\/blood-2012-09-459156","journal-title":"Blood"},{"key":"5275_CR96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/molmed.2009.00160","volume":"16","author":"RA Fraga-Silva","year":"2010","unstructured":"Fraga-Silva RA, Sorg BS, Wankhede M, deDeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ, Raizada MK, Ferreira AJ (2010) ACE2 activation promotes antithrombotic activity. Mol Med Camb Mass 16:210\u2013215. https:\/\/doi.org\/10.2119\/molmed.2009.00160","journal-title":"Mol Med Camb Mass"},{"key":"5275_CR97","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1055\/s-0038-1656136","volume":"77","author":"H Nishimura","year":"1997","unstructured":"Nishimura H, Tsuji H, Masuda H, Nakagawa K, Nakahara Y, Kitamura H, Kasahara T, Sugano T, Yoshizumi M, Sawada S, Nakagawa M (1997) Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 77:1189\u20131195","journal-title":"Thromb Haemost"},{"key":"5275_CR98","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.cir.90.1.362","volume":"90","author":"RT van Leeuwen","year":"1994","unstructured":"van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G (1994) Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90:362\u2013368. https:\/\/doi.org\/10.1161\/01.cir.90.1.362","journal-title":"Circulation"},{"key":"5275_CR99","doi-asserted-by":"publisher","unstructured":"Wright FL, Vogler TO, Moore EE et al (2020) Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection. J Am Coll Surg. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.05.007","DOI":"10.1016\/j.jamcollsurg.2020.05.007"},{"key":"5275_CR100","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39:345\u2013357. https:\/\/doi.org\/10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"key":"5275_CR101","doi-asserted-by":"publisher","unstructured":"Qu R, Ling Y, Zhang Y-H-Z et al (2020) Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.25767","DOI":"10.1002\/jmv.25767"},{"key":"5275_CR102","doi-asserted-by":"publisher","first-page":"106504","DOI":"10.1016\/j.intimp.2020.106504","volume":"84","author":"A-P Yang","year":"2020","unstructured":"Yang A-P, Liu J-P, Tao W-Q, Li H-M (2020) The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 84:106504. https:\/\/doi.org\/10.1016\/j.intimp.2020.106504","journal-title":"Int Immunopharmacol"},{"key":"5275_CR103","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood. 135:2033\u20132040. https:\/\/doi.org\/10.1182\/blood.2020006000","journal-title":"Blood."},{"key":"5275_CR104","doi-asserted-by":"publisher","unstructured":"Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis:1\u201314. https:\/\/doi.org\/10.1007\/s11239-020-02134-3","DOI":"10.1007\/s11239-020-02134-3"},{"key":"5275_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2040-7378-3-15","volume":"3","author":"M Nagai","year":"2011","unstructured":"Nagai M, Terao S, Vital SA, Rodrigues SF, Yilmaz G, Granger D (2011) Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension. Exp Transl Stroke Med 3:15. https:\/\/doi.org\/10.1186\/2040-7378-3-15","journal-title":"Exp Transl Stroke Med"},{"key":"5275_CR106","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","volume":"66","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Takeshita K, Kojima T et al (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res 66:276\u2013285. https:\/\/doi.org\/10.1016\/j.cardiores.2004.11.013","journal-title":"Cardiovasc Res"},{"key":"5275_CR107","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","volume":"14","author":"RA Fraga-Silva","year":"2008","unstructured":"Fraga-Silva RA, Pinheiro SVB, Gon\u00e7alves ACC, Alenina N, Bader M, Souza Santos RA (2008) The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Mol Med 14:28\u201335. https:\/\/doi.org\/10.2119\/2007-00073.Fraga-Silva","journal-title":"Mol Med"},{"key":"5275_CR108","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","volume":"314","author":"CP Sodhi","year":"2018","unstructured":"Sodhi CP, Wohlford-Lenane C, Yamaguchi Y et al (2018) Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Phys Lung Cell Mol Phys 314:L17\u2013L31. https:\/\/doi.org\/10.1152\/ajplung.00498.2016","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"5275_CR109","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.brainres.2012.02.010","volume":"1448","author":"MJ Waldner","year":"2012","unstructured":"Waldner MJ, Baethmann A, Uhl E, Lehmberg J (2012) Bradykinin-induced leukocyte- and platelet-endothelium interactions in the cerebral microcirculation. Brain Res 1448:163\u2013169. https:\/\/doi.org\/10.1016\/j.brainres.2012.02.010","journal-title":"Brain Res"},{"key":"5275_CR110","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood-2017-03-771501","volume":"129","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan V (2017) Complement and clot. Blood 129:2214\u20132215. https:\/\/doi.org\/10.1182\/blood-2017-03-771501","journal-title":"Blood"},{"key":"5275_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","volume":"5","author":"JH Foley","year":"2016","unstructured":"Foley JH, Walton BL, Aleman MM, O'Byrne AM, Lei V, Harrasser M, Foley KA, Wolberg AS, Conway EM (2016) Complement activation in arterial and venous thrombosis is mediated by plasmin. EBioMedicine 5:175\u2013182. https:\/\/doi.org\/10.1016\/j.ebiom.2016.02.011","journal-title":"EBioMedicine"},{"key":"5275_CR112","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, Lambris JD (2020) Complement as a target in COVID-19? Nat Rev Immunol 20:343\u2013344. https:\/\/doi.org\/10.1038\/s41577-020-0320-7","journal-title":"Nat Rev Immunol"},{"key":"5275_CR113","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","volume":"141","author":"CM Campbell","year":"2020","unstructured":"Campbell CM, Kahwash R (2020) Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation. 141:1739\u20131741. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047419","journal-title":"Circulation."},{"key":"5275_CR114","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.26355\/eurrev_202004_20875","volume":"24","author":"F Diurno","year":"2020","unstructured":"Diurno F, Numis FG, Porta G et al (2020) Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci 24:4040\u20134047. https:\/\/doi.org\/10.26355\/eurrev_202004_20875","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5275_CR115","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, Zeng X, Zhang S (2020) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 214:108393. https:\/\/doi.org\/10.1016\/j.clim.2020.108393","journal-title":"Clin Immunol"},{"key":"5275_CR116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0039-1694995","volume":"46","author":"T Iba","year":"2020","unstructured":"Iba T, Levi M, Levy JH (2020) Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost 46:89\u201395. https:\/\/doi.org\/10.1055\/s-0039-1694995","journal-title":"Semin Thromb Hemost"},{"key":"5275_CR117","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ (2019) Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol 10:55. https:\/\/doi.org\/10.3389\/fimmu.2019.00055","journal-title":"Front Immunol"},{"key":"5275_CR118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, du B, Qin Y, Gao P, Qin X, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S (2020) Coagulopathy and Antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38. https:\/\/doi.org\/10.1056\/NEJMc2007575","journal-title":"N Engl J Med"},{"key":"5275_CR119","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/ard.62.5.388","volume":"62","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R (2003) Antiphospholipid antibodies and infections. Ann Rheum Dis 62:388\u2013393. https:\/\/doi.org\/10.1136\/ard.62.5.388","journal-title":"Ann Rheum Dis"},{"key":"5275_CR120","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.thromres.2020.05.017","volume":"192","author":"F Galeano-Valle","year":"2020","unstructured":"Galeano-Valle F, Oblitas CM, Ferreiro-Maz\u00f3n MM, Alonso-Mu\u00f1oz J, del Toro-Cervera J, di Natale M, Demelo-Rodr\u00edguez P (2020) Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res 192:113\u2013115. https:\/\/doi.org\/10.1016\/j.thromres.2020.05.017","journal-title":"Thromb Res"},{"key":"5275_CR121","doi-asserted-by":"publisher","unstructured":"Bertin D, Brodovitch A, Beziane A, Hug S, Bouamri A, Mege JL, Bardin N (2020) Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.41409","DOI":"10.1002\/art.41409"},{"key":"5275_CR122","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cca.2020.06.024","volume":"509","author":"S Mehta","year":"2020","unstructured":"Mehta S, Bhandari S, Mehta S (2020) Cautious interpretation of antiphospholipid antibodies in COVID-19. Clin Chim Acta Int J Clin Chem 509:166. https:\/\/doi.org\/10.1016\/j.cca.2020.06.024","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"5275_CR123","doi-asserted-by":"publisher","unstructured":"Ayerbe L, Risco C, Ayis S (2020) The association between treatment with heparin and survival in patients with Covid-19. J Thromb Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-020-02162-z","DOI":"10.1007\/s11239-020-02162-z"},{"key":"5275_CR124","doi-asserted-by":"publisher","unstructured":"Menezes-Rodrigues FS, Padr\u00e3o Tavares JG, Pires de Oliveira M, Guzella de Carvalho R, Ruggero Errante P, Omar Taha M, Fagundes DJ, Caricati-Neto A (2020) Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14902","DOI":"10.1111\/jth.14902"},{"key":"5275_CR125","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10067-020-05145-w","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Anirvan P (2020) Reply to rheumatologists\u2019 perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Clin Rheumatol 39:2099\u20132100. https:\/\/doi.org\/10.1007\/s10067-020-05145-w","journal-title":"Clin Rheumatol"},{"key":"5275_CR126","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18:1023\u20131026. https:\/\/doi.org\/10.1111\/jth.14810","journal-title":"J Thromb Haemost"},{"key":"5275_CR127","doi-asserted-by":"publisher","unstructured":"Gavioli EM, Sikorska G, Man A et al (2020) Current perspectives of anticoagulation in patients with COVID-19. J Cardiovasc Pharmacol. https:\/\/doi.org\/10.1097\/FJC.0000000000000861","DOI":"10.1097\/FJC.0000000000000861"},{"key":"5275_CR128","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fmed.2016.00064","volume":"3","author":"A Ozolina","year":"2016","unstructured":"Ozolina A, Sarkele M, Sabelnikovs O, Skesters A, Jaunalksne I, Serova J, Ievins T, Bjertnaes LJ, Vanags I (2016) Activation of coagulation and fibrinolysis in acute respiratory distress syndrome: a prospective pilot study. Front Med 3:64. https:\/\/doi.org\/10.3389\/fmed.2016.00064","journal-title":"Front Med"},{"key":"5275_CR129","doi-asserted-by":"publisher","unstructured":"Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD (2020) Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14828","DOI":"10.1111\/jth.14828"},{"key":"5275_CR130","doi-asserted-by":"publisher","unstructured":"Christie DB, Nemec HM, Scott AM et al (2020) Early outcomes with utilization of tissue plasminogen activator in COVID-19 associated respiratory distress: a series of five cases. J Trauma Acute Care Surg. https:\/\/doi.org\/10.1097\/TA.0000000000002787","DOI":"10.1097\/TA.0000000000002787"},{"key":"5275_CR131","doi-asserted-by":"publisher","unstructured":"Choudhury R, Barrett CD, Moore HB et al (2020) Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis. World J Emerg Surg 15. https:\/\/doi.org\/10.1186\/s13017-020-00305-4","DOI":"10.1186\/s13017-020-00305-4"},{"key":"5275_CR132","doi-asserted-by":"publisher","unstructured":"Whyte CS, Morrow GB, Mitchell JL et al (2020) Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14872","DOI":"10.1111\/jth.14872"},{"key":"5275_CR133","first-page":"312","volume":"122","author":"DE Vaughan","year":"2011","unstructured":"Vaughan DE (2011) PAI-1 antagonists: the promise and the peril. Trans Am Clin Climatol Assoc 122:312\u2013325","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"5275_CR134","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1111\/jcmm.12875","volume":"20","author":"L Gong","year":"2016","unstructured":"Gong L, Proulle V, Fang C, Hong Z, Lin Z, Liu M, Xue G, Yuan C, Lin L, Furie B, Flaumenhaft R, Andreasen P, Furie B, Huang M (2016) A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase. J Cell Mol Med 20:1851\u20131860. https:\/\/doi.org\/10.1111\/jcmm.12875","journal-title":"J Cell Mol Med"},{"key":"5275_CR135","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fphar.2017.00489","volume":"8","author":"B Yu","year":"2017","unstructured":"Yu B, Zhang G, Jin L et al (2017) Inhibition of PAI-1 activity by Toddalolactone as a mechanism for promoting blood circulation and removing stasis by Chinese herb Zanthoxylum nitidum var. tomentosum. Front Pharmacol 8:489. https:\/\/doi.org\/10.3389\/fphar.2017.00489","journal-title":"Front Pharmacol"},{"key":"5275_CR136","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa S, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699\u2013709. https:\/\/doi.org\/10.1056\/NEJM200103083441001","journal-title":"N Engl J Med"},{"key":"5275_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-014-0050-7","volume":"3","author":"T Ikezoe","year":"2015","unstructured":"Ikezoe T (2015) Thrombomodulin\/activated protein C system in septic disseminated intravascular coagulation. J Intensive Care 3:1. https:\/\/doi.org\/10.1186\/s40560-014-0050-7","journal-title":"J Intensive Care"},{"key":"5275_CR138","doi-asserted-by":"publisher","unstructured":"Viecca M, Radovanovic D, Forleo GB, Santus P (2020) Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2020.104950","DOI":"10.1016\/j.phrs.2020.104950"},{"key":"5275_CR139","doi-asserted-by":"publisher","unstructured":"Thomas G (2020) Renin-angiotensin system inhibitors in COVID-19. Cleve Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc009","DOI":"10.3949\/ccjm.87a.ccc009"},{"key":"5275_CR140","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653\u20131659. https:\/\/doi.org\/10.1056\/NEJMsr2005760","journal-title":"N Engl J Med"},{"key":"5275_CR141","doi-asserted-by":"publisher","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","volume":"158","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yu J, Pan L-Y, Jiang H-Y (2020) ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol Res 158:104927. https:\/\/doi.org\/10.1016\/j.phrs.2020.104927","journal-title":"Pharmacol Res"},{"key":"5275_CR142","doi-asserted-by":"publisher","unstructured":"Pirola CJ, Sookoian S (2020) Estimation of RAAS-inhibitor effect on the COVID-19 outcome: a meta-analysis. J Inf Secur. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.052","DOI":"10.1016\/j.jinf.2020.05.052"},{"key":"5275_CR143","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMc2021225","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020) Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. DOI: 10.1056\/NEJMoa2007621. N Engl J Med 382:2582. https:\/\/doi.org\/10.1056\/NEJMc2021225","journal-title":"N Engl J Med"},{"key":"5275_CR144","doi-asserted-by":"publisher","unstructured":"Guo X, Zhu Y, Hong Y (2020, 1979) Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension:a meta-analysis. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15572","DOI":"10.1161\/HYPERTENSIONAHA.120.15572"},{"key":"5275_CR145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1470320318782623","volume":"19","author":"Y Suo","year":"2018","unstructured":"Suo Y, Zhang Z, Fu H, Zhang Y, Yuan M, Wang Y, Goudis CA, Tse G, Liu T, Li G (2018) Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation. J Renin-Angiotensin Aldosterone Syst 19:19. https:\/\/doi.org\/10.1177\/1470320318782623","journal-title":"J Renin-Angiotensin Aldosterone Syst"},{"key":"5275_CR146","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fmed.2016.00061","volume":"3","author":"AH Schmaier","year":"2016","unstructured":"Schmaier AH (2016) A novel antithrombotic mechanism mediated by the receptors of the Kallikrein\/Kinin and renin-angiotensin systems. Front Med 3:61. https:\/\/doi.org\/10.3389\/fmed.2016.00061","journal-title":"Front Med"},{"key":"5275_CR147","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1753944716644130","volume":"10","author":"R D\u00fcsing","year":"2016","unstructured":"D\u00fcsing R (2016) Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering. Ther Adv Cardiovasc Dis 10:151\u2013161. https:\/\/doi.org\/10.1177\/1753944716644130","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"5275_CR148","doi-asserted-by":"publisher","first-page":"9040457","DOI":"10.1155\/2016\/9040457","volume":"2016","author":"M Marin\u0161ek","year":"2016","unstructured":"Marin\u0161ek M, Sinkovi\u010d A (2016) Ramipril and losartan exert a similar long-term effect upon markers of heart failure, endogenous fibrinolysis, and platelet aggregation in survivors of ST-elevation myocardial infarction: a single centre randomized trial. Biomed Res Int 2016:9040457\u20139040457. https:\/\/doi.org\/10.1155\/2016\/9040457","journal-title":"Biomed Res Int"},{"key":"5275_CR149","doi-asserted-by":"publisher","unstructured":"Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Panigada M, Aliberti S, Blasi F, Tedesco F, Peyvandi F (2020) Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.006","DOI":"10.1016\/j.jaci.2020.05.006"},{"key":"5275_CR150","doi-asserted-by":"publisher","unstructured":"Maglakelidze N, Manto KM, Craig TJ (2020) A review: does complement or the contact system have a role in protection or pathogenesis of COVID-19? Pulm Ther. https:\/\/doi.org\/10.1007\/s41030-020-00118-5","DOI":"10.1007\/s41030-020-00118-5"},{"key":"5275_CR151","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3346\/jkms.2020.35.e176","volume":"35","author":"AY Gasparyan","year":"2020","unstructured":"Gasparyan AY, Misra DP, Yessirkepov M, Zimba O (2020) Perspectives of immune therapy in coronavirus disease 2019. J Korean Med Sci 35:e176. https:\/\/doi.org\/10.3346\/jkms.2020.35.e176","journal-title":"J Korean Med Sci"},{"key":"5275_CR152","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21307\/immunohematology-2020-006","volume":"35","author":"DR Branch","year":"2019","unstructured":"Branch DR (2019) Serologic problems associated with administration of intravenous immune globulin (IVIg). Immunohematology 35:13\u201315","journal-title":"Immunohematology"},{"key":"5275_CR153","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2710.2011.01287.x","volume":"37","author":"P Bentley","year":"2012","unstructured":"Bentley P, Rosso M, Sadnicka A, Israeli-Korn S, Laffan M, Sharma P (2012) Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure. J Clin Pharm Ther 37:286\u2013290. https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01287.x","journal-title":"J Clin Pharm Ther"},{"key":"5275_CR154","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/j.1537-2995.2012.03868.x","volume":"52","author":"DA Drelich","year":"2012","unstructured":"Drelich DA, Bray PF, Herman JH (2012) Immunoglobulin therapy and thrombosis: coincidence or causation? Transfusion (Paris) 52:2075\u20132077. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03868.x","journal-title":"Transfusion (Paris)"},{"key":"5275_CR155","doi-asserted-by":"publisher","first-page":"CD013600","DOI":"10.1002\/14651858.CD013600","volume":"5","author":"SJ Valk","year":"2020","unstructured":"Valk SJ, Piechotta V, Chai KL et al (2020) Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev 5:CD013600. https:\/\/doi.org\/10.1002\/14651858.CD013600","journal-title":"Cochrane Database Syst Rev"},{"key":"5275_CR156","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI138745","volume":"130","author":"EM Bloch","year":"2020","unstructured":"Bloch EM, Shoham S, Casadevall A et al (2020) Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 130:2757\u20132765. https:\/\/doi.org\/10.1172\/JCI138745","journal-title":"J Clin Invest"},{"key":"5275_CR157","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10067-019-04832-7","volume":"39","author":"JL Baudel","year":"2020","unstructured":"Baudel JL, Vigneron C, Pras-Landre V, Joffre J, Marjot F, Ait-Oufella H, Big\u00e9 N, Maury E, Guidet B, Fain O, Mekinian A (2020) Transfusion-related acute lung injury (TRALI) after intravenous immunoglobulins: French multicentre study and literature review. Clin Rheumatol 39:541\u2013546. https:\/\/doi.org\/10.1007\/s10067-019-04832-7","journal-title":"Clin Rheumatol"},{"key":"5275_CR158","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3343\/alm.2016.36.4.393","volume":"36","author":"S Chun","year":"2016","unstructured":"Chun S, Chung CR, Ha YE, Han TH, Ki CS, Kang ES, Park JK, Peck KR, Cho D (2016) Possible transfusion-related acute lung injury following convalescent plasma transfusion in a patient with Middle East respiratory syndrome. Ann Lab Med 36:393\u2013395. https:\/\/doi.org\/10.3343\/alm.2016.36.4.393","journal-title":"Ann Lab Med"},{"key":"5275_CR159","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.autrev.2020.102569","volume":"102569","author":"J Alijotas-Reig","year":"2020","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Belizna C, Selva-O'Callaghan A, Pardos-Gea J, Quintana A, Mekinian A, Anunciacion-Llunell A, Mir\u00f3-Mur F (2020) Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev 102569:102569. https:\/\/doi.org\/10.1016\/j.autrev.2020.102569","journal-title":"Autoimmun Rev"},{"key":"5275_CR160","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39:2055\u20132062. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"key":"5275_CR161","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","volume":"111","author":"C Perricone","year":"2020","unstructured":"Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R (2020) The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. J Autoimmun 111:102468. https:\/\/doi.org\/10.1016\/j.jaut.2020.102468","journal-title":"J Autoimmun"},{"key":"5275_CR162","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2174\/138161212799504759","volume":"18","author":"AY Gasparyan","year":"2012","unstructured":"Gasparyan AY, Ayvazyan L, Cocco G, Kitas GD (2012) Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des 18:1543\u20131555. https:\/\/doi.org\/10.2174\/138161212799504759","journal-title":"Curr Pharm Des"},{"key":"5275_CR163","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/rheumatology\/kex378","volume":"57","author":"K Schreiber","year":"2018","unstructured":"Schreiber K, Breen K, Parmar K, Rand JH, Wu XX, Hunt BJ (2018) The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Rheumatol Oxf Engl 57:120\u2013124. https:\/\/doi.org\/10.1093\/rheumatology\/kex378","journal-title":"Rheumatol Oxf Engl"},{"key":"5275_CR164","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1517\/17425255.2015.1076391","volume":"11","author":"AY Gasparyan","year":"2015","unstructured":"Gasparyan AY, Ayvazyan L, Yessirkepov M, Kitas GD (2015) Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol 11:1781\u20131794. https:\/\/doi.org\/10.1517\/17425255.2015.1076391","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5275_CR165","doi-asserted-by":"publisher","unstructured":"Deftereos S, Giannopoulos G, Vrachatis DA et al (2020) Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Eur Heart J Cardiovasc Pharmacother. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa033","DOI":"10.1093\/ehjcvp\/pvaa033"},{"key":"5275_CR166","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/rheumatology\/keaa217","volume":"59","author":"S Piantoni","year":"2020","unstructured":"Piantoni S, Patroni A, Toniati P, Furloni R, Franceschini F, Andreoli L, Scarsi M (2020) Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease. Rheumatol Oxford 59:1769\u20131770. https:\/\/doi.org\/10.1093\/rheumatology\/keaa217","journal-title":"Rheumatol Oxford"},{"key":"5275_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41366-020-0598-3","volume":"2020","author":"AP Demidowich","year":"2005","unstructured":"Demidowich AP, Levine JA, Apps R et al (2005) Colchicine\u2019s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. Int J Obes 2020:1\u20137. https:\/\/doi.org\/10.1038\/s41366-020-0598-3","journal-title":"Int J Obes"},{"key":"5275_CR168","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395:e30\u2013e31. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4","journal-title":"Lancet"},{"key":"5275_CR169","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","volume":"79","author":"A Sepriano","year":"2020","unstructured":"Sepriano A, Kerschbaumer A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, Bijlsma JW, Burmester GR, de Wit M, Falzon L, Landew\u00e9 R (2020) Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 79:760\u2013770. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216653","journal-title":"Ann Rheum Dis"},{"key":"5275_CR170","doi-asserted-by":"publisher","first-page":"e0220178","DOI":"10.1371\/journal.pone.0220178","volume":"14","author":"B Castagn\u00e9","year":"2019","unstructured":"Castagn\u00e9 B, Viprey M, Martin J, Schott AM, Cucherat M, Soubrier M (2019) Cardiovascular safety of tocilizumab: a systematic review and network meta-analysis. PLoS One 14:e0220178. https:\/\/doi.org\/10.1371\/journal.pone.0220178","journal-title":"PLoS One"},{"key":"5275_CR171","doi-asserted-by":"publisher","unstructured":"Brito CA, Paiva JG, Pimentel FN, Guimar\u00e3es RS, Moreira MR (2020) COVID-19 in patients with rheumatological diseases treated with anti-TNF. Ann Rheum Dis:annrheumdis-2020-218171. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218171","DOI":"10.1136\/annrheumdis-2020-218171"},{"key":"5275_CR172","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","volume":"173","author":"SA Johannesdottir","year":"2013","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Dekkers OM, Cannegieter SC, J\u00f8rgensen JOL, Ehrenstein V, Vandenbroucke JP, Pedersen L, S\u00f8rensen HT (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173:743\u2013752. https:\/\/doi.org\/10.1001\/jamainternmed.2013.122","journal-title":"JAMA Intern Med"},{"key":"5275_CR173","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05275-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T23:37:54Z","timestamp":1625960274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05275-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":173,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5275"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05275-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any institution or association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}